GW Pharmaceuticals

Biotech

Encoded bags $135M to push 'precision gene therapy' into phase 1

Encoded Therapeutics raised $135 million to advance a precision gene therapy that could address more symptoms of Dravet syndrome than seizures.
Amirah Al Idrus Jul 22, 2020 6:00am

After Dravet hiccup, Zogenix's Fintepla logs Lennox-Gastaut win

Feb 7, 2020 10:45am

Zogenix data blunder trips up FDA filing for epilepsy drug Fintepla

Apr 9, 2019 6:54am

Ovid, Takeda add 2 rare epilepsies to rare drug pact

Jul 18, 2018 10:56am

Chasing GW, Zogenix scores a win in second Dravet phase 3

Jul 12, 2018 9:10am

Kalytera's cannabis-based GVHD drug gathers steam

Jun 21, 2018 10:04am